Table 4.

Antimicrobial resistance profiles of individual colistin-resistant bacterial strains from animal and human sources

Antibiotics	E. coli		K. pneumoniae		P. aeruginosa		A. baumannii		P. mirabilis
	Animal	Human	Animal	Human	Animal	Human	Animal	Human	Animal	Human
	(n = 91)	(n = 3)	(n =12)	(n = 1)	(n = 2)	(n = 0)	(n = 0)	(n = 3)	(n = 20)	(n = 10)
Co-trimoxazole	64 (70%)	3 (100%)	5 (42%)	1 (100%)	2 (100%)	–	–	3 (100%)	8 (40%)	10 (100%)
Chloramphenicol	64 (70%)	3 (100%)	5 (42%)	1 (100%)	2 (100%)	–	–	3 (100%)	8 (40%)	4 (40%)
Moxifloxacin	59 (65%)	2(67%)	5 (42%)	1 (100%)	2 (100%)	–	–	3 (100%)	3 (15%)	4 (40%)
Levofloxacin	21 (23%)	1 (33%)	3 (25%)	1 (100%)	2 (100%)	–	–	2 (75%)	3 (15%)	1 (10%)
Ciprofloxacin	38 (42%)	0 (0%)	2 (17%)	1 (100%)	2 (100%)	–	–	3 (100%)	5 (25%)	1 (10%)
Co-amoxiclav	39 (43%)	2 (67%)	1 (8%)	1 (100%)	0 (0%)	–	–	3 (100%)	6 (30%)	1 (10%)
Cefotaxime	35 (38%)	1 (33%)	1 (8%)	1 (100%)	0 (0%)	–	–	2 (75%)	3 (15%)	1 (10%)
Cefixime	29 (32%)	2 (67%)	3 (25%)	1 (100%)	0 (0%)	–	–	3 (100%)	6 (30%)	3 (30%)
Cefuroxime	27 (30%)	2 (67%)	0 (0%)	1 (100%)	0 (0%)	–	–	3 (100%)	7 (35%)	3 (30%)
Ceftriaxone	27 (30%)	2 (67%)	1 (8%)	1 (100%)	0 (0%)	–	–	3 (100%)	7 (35%)	3 (30%)
Ceftazidime	27 (30%)	1 (33%)	0 (0%)	1 (100%)	0 (0%)	–	–	3 (100%)	1 (5%)	3 (30%)
Amikacin	16 (18%)	1 (33%)	3 (25%)	1 (100%)	0 (0%)	–	–	2 (75%)	2 (10%)	0 (0%)
Imipenem	12 (13%)	1 (33%)	3 (25%)	1 (100%)	0 (0%)	–	–	1 (33%)	0 (0%)	2 (20%)
Cefoperazone-sulbactam	7 (8%)	1 (33%)	2 (17%)	1 (100%)	1 (50%)	–	–	2 (67%)	2 (10%)	0 (0%)
Piperacillin-tazobactam	9 (10%)	0 (0%)	0 (0%)	1 (100%)	0 (0%)	–	–	0 (0%)	2 (10%)	1 (10%)
Meropenem	9 (10%)	1 (33%)	1 (8%)	1 (100%)	0 (0%)	–	–	3 (100%)	2 (10%)	0 (0%)